Instil Bio, Inc. (TIL)

Instil Bio Statistics

Total Valuation

Instil Bio has a market cap or net worth of $48.02 million. The enterprise value is $53.27 million.

Market Cap	48.02M
Enterprise Value	53.27M

Important Dates

The next estimated earnings date is Tuesday, March 3, 2026, before market open.

Earnings Date	Mar 3, 2026
Ex-Dividend Date	n/a

Share Statistics

Instil Bio has 6.78 million shares outstanding. The number of shares has increased by 1.53% in one year.

Current Share Class	6.78M
Shares Outstanding	6.78M
Shares Change (YoY)	+1.53%
Shares Change (QoQ)	+2.44%
Owned by Insiders (%)	8.81%
Owned by Institutions (%)	23.41%
Float	3.23M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.40
P/TBV Ratio	0.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 34.45, with a Debt / Equity ratio of 0.71.

Current Ratio	34.45
Quick Ratio	13.98
Debt / Equity	0.71
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-7.95

Financial Efficiency

Return on equity (ROE) is -50.60% and return on invested capital (ROIC) is -15.47%.

Return on Equity (ROE)	-50.60%
Return on Assets (ROA)	-14.91%
Return on Invested Capital (ROIC)	-15.47%
Return on Capital Employed (ROCE)	-28.04%
Revenue Per Employee	n/a
Profits Per Employee	-$5.36M
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -66.24% in the last 52 weeks. The beta is 2.11, so Instil Bio's price volatility has been higher than the market average.

Beta (5Y)	2.11
52-Week Price Change	-66.24%
50-Day Moving Average	11.10
200-Day Moving Average	19.63
Relative Strength Index (RSI)	31.12
Average Volume (20 Days)	260,440

Short Selling Information

The latest short interest is 561,996, so 8.29% of the outstanding shares have been sold short.

Short Interest	561,996
Short Previous Month	544,356
Short % of Shares Out	8.29%
Short % of Float	17.41%
Short Ratio (days to cover)	9.60

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-57.78M
Pretax Income	-75.08M
Net Income	-75.08M
EBITDA	-56.52M
EBIT	-57.78M
Earnings Per Share (EPS)	-$11.37

Balance Sheet

The company has $79.67 million in cash and $84.92 million in debt, with a net cash position of -$5.25 million or -$0.77 per share.

Cash & Cash Equivalents	79.67M
Total Debt	84.92M
Net Cash	-5.25M
Net Cash Per Share	-$0.77
Equity (Book Value)	120.42M
Book Value Per Share	17.76
Working Capital	190.57M

Cash Flow

Operating Cash Flow	-40.10M
Capital Expenditures	n/a
Free Cash Flow	-40.10M
FCF Per Share	-$5.91

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Instil Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.53%
Shareholder Yield	-1.53%
Earnings Yield	-156.35%
FCF Yield	-83.52%

Analyst Forecast

The average price target for Instil Bio is $125.00, which is 1,665.54% higher than the current price. The consensus rating is "Buy".

Price Target	$125.00
Price Target Difference	1,665.54%
Analyst Consensus	Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 8, 2023. It was a reverse split with a ratio of 1:20.

Last Split Date	Dec 8, 2023
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	2